While we failed to identify any study that reports a specific deletion of JunD in an oncogenic KRAS-driven mouse PC model, a recent transgenic mice study reported that JunD is required in oncogenic KRAS-driven mouse lung tumour model [46]. This evidence concerns the gene KRAS and pachyonychia congenita.